Authors: Breton, C Chellil, H Kabbaj-Benmansour, M Carnazzi, E Seyer, R Phalipou, S Morin, D Durroux, T Zingg, H Barberis, C Mouillac, B

Citation: C. Breton et al., Direct identification of human oxytocin receptor-binding domains using a photoactivatable cyclic peptide antagonist - Comparison with the human V-1a vasopressin receptor, J BIOL CHEM, 276(29), 2001, pp. 26931-26941

Authors: Cotte, N Balestre, MN Aumelas, A Mahe, E Phalipou, S Morin, D Hibert, M Manning, M Durroux, T Barberis, C Mouillac, B

Citation: N. Cotte et al., Conserved aromatic residues in the transmembrane region VI of the V-1a vasopressin receptor differentiate agonist vs. antagonist ligand binding, EUR J BIOCH, 267(13), 2000, pp. 4253-4263

Authors: Durroux, T Peter, M Turcatti, G Chollet, A Balestre, MN Barberis, C Seyer, R

Citation: T. Durroux et al., Fluorescent pseudo-peptide linear vasopressin antagonists: Design, synthesis, and applications, J MED CHEM, 42(7), 1999, pp. 1312-1319

Authors: Tran, D Stelly, N Tordjmann, T Durroux, T Dufour, MN Forchioni, A Seyer, R Claret, M Guillon, C

Citation: D. Tran et al., Distribution of signaling molecules involved in vasopressin-induced Ca2+ mobilization in rat hepatocyte multiplets, J HIST CYTO, 47(5), 1999, pp. 601-616

Authors: Tran, D Durroux, T Stelly, N Seyer, R Tordjmann, T Combettes, L Claret, M

Citation: D. Tran et al., Visualization of cell surface vasopressin V1a receptors in rat hepatocyteswith a fluorescent linear antagonist, J HIST CYTO, 47(3), 1999, pp. 401-409